September 28, 2023
Chaired by Professor Ricard Cervera, Hospital Clínic de Barcelona, Barcelona, ES, this platform delivers open-access education that is informed by patients, curated by world leaders, and endorsed by expert societies—supporting healthcare professionals (HCPs) worldwide.
Currently, with 2.2k unique users across 100 countries, the platform provides HCPs and researchers with instant access to expert opinions and the latest evidence-based information on lupus, to aid in treatment decisions and, ultimately, improve the lives of patients with lupus globally.
“We have been working very hard over the last year at the Lupus Hub.
The Lupus Hub aims to deliver valuable, up-to-date information on the most exciting advances in lupus, making the hub a go-to site for all HCPs in this space. In order to reach this objective, we have included up-to-date information on the most recent trials on potential new drugs for lupus, including telitacicept, dapirolizumab pegol, zetomipzomib, baricitinib, and deucravacitinib. Also, we have included additional information on recently approved drugs for lupus, such as voclosporin and anifrolumab, and the new indications (lupus nephritis) for belimumab, the first biological drug approved for lupus; CD19 CAR T-cell therapy has also received special attention at the Lupus Hub.
We have also covered the EULAR and ACR Convergence congresses and produced a webinar on low lupus disease activity versus remission as treat-to-target goals in lupus, with the participation of our steering committee members.”
- Professor Ricard Cervera, Hospital Clínic de Barcelona, Barcelona, ES.
Looking to receive the latest news, project updates, and new offerings?